Further, treatment with EO, a TFEB inhibitor, significantly suppressed the IHT-enhanced Aβ loading in AD mice brains (Fig. 9A and B), along with a significant reduction in nuclear TFEB expression in DAM (Fig. 9C and D). The gene discussed is TFEB; the disease is Alzheimer disease.